Benidipine hydrochloride, metoprolol succinate tablets
Hypertension is a silent yet dangerous condition that can lead to heart disease, kidney damage, and stroke if left uncontrolled. For patients who require more than single-drug therapy, combination treatments offer superior control and better long-term outcomes. BENIPRIME M 25 is a scientifically formulated antihypertensive that combines two powerful agents — Benidipine (4 mg) and Metoprolol Succinate 25 mg — for effective and sustained blood pressure management.
Introduction to BENIPRIME M 25
BENIPRIME M 25 is a fixed-dose combination of a calcium channel blocker (Benidipine) and a beta-blocker (Metoprolol Succinate). This dual-action approach not only lowers elevated blood pressure but also provides added cardiovascular protection, making it ideal for patients with co-existing heart conditions such as angina, arrhythmias, or heart failure.
Benidipine helps in relaxing and dilating blood vessels, reducing peripheral resistance and improving blood flow.
Metoprolol Succinate, a cardioselective beta-blocker, lowers heart rate and cardiac output, helping to reduce blood pressure and heart workload.
Together, they offer complementary mechanisms to achieve stable and effective blood pressure control.
Key Benefits of BENIPRIME M 25
BENIPRIME M 25 delivers multiple health benefits beyond just lowering blood pressure:
Effective control of systolic and diastolic blood pressure
Reduced risk of cardiovascular events such as stroke or heart attack
Improves exercise tolerance in patients with angina
Minimizes heart rate variability and reduces cardiac strain
Provides 24-hour blood pressure control with once-daily dosing
Improves patient compliance with a fixed-dose combination
Key Features and Ingredients
Key Features:
Dual-action antihypertensive therapy in a single tablet
Once-daily extended-release formula
Suitable for long-term management of hypertension
Reduces pill burden and increases patient adherence
Recommended by cardiologists and general physicians
Ingredients:
Benidipine 4 mg: A long-acting dihydropyridine calcium channel blocker that relaxes arterial walls and lowers vascular resistance.
Metoprolol Succinate 25 mg: A beta-1 selective beta-blocker that decreases heart rate and cardiac output, supporting the heart and reducing pressure.
Usage and Dosage
How to Use BENIPRIME M 25:
The usual dose is one tablet once daily, preferably in the morning.
Take it with or without food as directed by your physician.
Swallow the tablet whole without crushing or chewing.
Regular monitoring of blood pressure and heart rate is recommended.
Dose adjustments may be required based on clinical response and individual tolerability.
Precautions:
Not recommended for use in patients with severe bradycardia, hypotension, or advanced heart block.
Use with caution in patients with liver or kidney impairment.
Always consult a healthcare provider before initiating therapy.
Additional Benefits of BENIPRIME M 25
What sets BENIPRIME M 25 apart is its synergistic mechanism of action. While Benidipine 4 mg acts on the blood vessels, Metoprolol works on the heart — together offering complete cardiovascular protection. This makes the combination ideal for patients:
With stage 2 or resistant hypertension
Who have suffered a prior cardiac event
With co-morbid conditions like angina or left ventricular hypertrophy
Conclusion
BENIPRIME M 25, containing Benidipine 4 mg and Metoprolol Succinate (25 mg), is a powerful, evidence-based solution for long-term management of hypertension. By targeting both vascular resistance and cardiac output, it provides comprehensive blood pressure control and protects against future cardiovascular complications. Its once-daily dosing and excellent tolerability make it a trusted choice for physicians and patients alike.
Choose BENIPRIME M 25 – for balanced, effective, and dependable hypertension management.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
